Nausea, vomiting, diarrhea, and constipation are the most commonly reported adverse events for both medications, and the clinical trial data gives us precise numbers to compare
223 Hence, related to hypoxia and ER stress genes could be considered as precise therapeutics to control the IR
Stay ahead in 2025: Discover whats on the horizon for GLP-1 compounding as we navigate evolving FDA guidelines and state Boards of Pharmacy regulations
Persistent or worsening symptoms despite dietary modifications and over-the-counter interventions lasting more than 2-3 weeks should be discussed with your prescribing clinician, as this may indicate inadequate tolerance to the current dose or the need for alternative management strategies
Chen Y, Chen B, Wu T et al (2023) Cryo-EM structure of human -opioid receptor-Gi complex bound to an endogenous agonist dynorphin A